TP53 and lung cancer: Our study revealed that miR-4507 targets TP53 to promote the malignant progression of NSCLC, to further demonstrate this regulation on histological level, we used In situ hybridization and Immunohistochemistry assay to detect miR-4507 and P53 expression in 75 lung cancer tissues.